Telescope Innovations Corp (TELI) AI Stock Analysis

Telescope Innovations Corp

(CNQX:TELI)

Select Model

Rating:42Neutral

Price Target:CAD 0.40▲(31.15% Upside)

Action:initiatedcoverage

Date:09/24/26

The overall score is constrained by very weak profitability, deteriorating margins, and persistent cash burn despite strong revenue growth and a balance sheet that still shows positive equity and moderate leverage, while technical indicators confirm a clear downtrend with soft momentum and the loss-based valuation offers limited current support, placing the stock near the lower end of the scoring range.

Positive Factors

Rapid TTM Revenue GrowthThe sharp TTM revenue increase indicates that the company is expanding its reported top line and gaining commercial activity. If retained, this growth can create operating leverage and provide a broader base from which management may improve profitability over the next several quarters.

Negative Factors

Very Weak ProfitabilityExtremely low gross margin and deeply negative operating and net margins show that current revenue is not translating into sustainable earnings. This weakens the quality of growth, limits internally generated funding, and suggests that substantial cost improvements are needed before scale can create durable profit.

Telescope Innovations Corp (TELI) vs. iShares MSCI Canada ETF (EWC)

Market Cap: CAD 24.65M
Dividend Yield: ―
Average Volume (3M): 69.57K
Price to Earnings (P/E): 5.7
Beta (1Y): 0.40
Revenue Growth: 94.58%
EPS Growth: ―
Country: Canada
Employees: 22
Sector: Healthcare
Sector Strength: 51
Industry: Biotechnology

Telescope Innovations Corp Business Overview & Revenue Model

Company Description

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that e...

Telescope Innovations Corp Financial Statement Overview

Summary

Revenue has scaled quickly from near zero to about $7.3M TTM, but net losses over $4M, sharply deteriorating margins, and deeply negative operating and free cash flow indicate weak overall financial quality despite a still-moderate leverage profile and positive equity base.

Income Statement

33Negative

Balance Sheet

45Neutral

Cash Flow

22Negative

Financial statement breakdown
Breakdown	TTM	Nov 2025	Nov 2024	Nov 2023	Nov 2022	Aug 2021
Income Statement
Total Revenue	7.30M	4.78M	4.27M	2.82M	595.40K	0
Gross Profit	162.28K	194.97K	4.27M	2.82M	595.40K	0
EBITDA	-3.98M	-587.02K	-456.60K	-421.78K	-5.49M	-3.14M
Net Income	-4.09M	-1.56M	-1.32M	-718.09K	-5.73M	-4.03M
Balance Sheet
Total Assets	6.84M	7.28M	5.69M	3.29M	3.02M	4.07M
Cash, Cash Equivalents and Short-Term Investments	1.33M	2.70M	337.01K	356.81K	719.49K	3.29M
Total Debt	2.71M	2.25M	2.03M	0	0	0
Total Liabilities	3.45M	5.27M	4.17M	713.18K	1.35M	247.07K
Stockholders Equity	3.39M	2.00M	1.52M	2.58M	1.67M	3.83M
Cash Flow
Free Cash Flow	-6.26M	-672.66K	-19.80K	-1.79M	-2.57M	-1.54M
Operating Cash Flow	-5.69M	252.06K	19.80K	-1.76M	-1.37M	-941.00K
Investing Cash Flow	-572.38K	-924.72K	-39.60K	-35.77K	-1.20M	-599.57K
Financing Cash Flow	6.48M	3.04M	0	1.43M	0	4.79M

Telescope Innovations Corp Technical Analysis

Technical Analysis SentimentNegative

Last Price0.30

Price Trends

50DMA0.44Negative

100DMA0.53Negative

200DMA0.50Negative

Market Momentum

MACD-0.04Positive

RSI27.02Positive

STOCH19.53Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:TELI, the sentiment is Negative. The current price of 0.30 is below the 20-day moving average (MA) of 0.37, below the 50-day MA of 0.44, and below the 200-day MA of 0.50, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 27.02 is Positive, neither overbought nor oversold. The STOCH value of 19.53 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:TELI.

Telescope Innovations Corp Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

TSE:TELI against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TSE:COV	70Outperform	CAD 122.35M	28.16	15.04%	―	4.11%	88.39%
TSE:MBX	52Neutral	CAD 41.09M	-8.50	-18.83%	―	-27.13%	-1752.63%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TSE:MIR	47Neutral	CAD 37.19M	-11.36	12.68%	―	45.72%	35.82%
TSE:TELI	42Neutral	CAD 24.65M	5.71	114.66%	―	94.58%	―
TSE:HEM	39Underperform	CAD 11.63M	-2.43	92.37%	―	―	16.04%
TSE:KNE	37Underperform	CAD 6.15M	-2.05	273.53%	―	―	―

* Healthcare Sector Average

Performance Comparison

TSE:TELI and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
TSE:TELI	Telescope Innovations Corp	0.30	-0.09	-21.79%
TSE:COV	Covalon Technologies	4.43	2.33	110.95%
TSE:HEM	Hemostemix Inc	0.06	-0.04	-42.11%
TSE:KNE	Kane Biotech	0.03	0.00	0.00%
TSE:MBX	Microbix Biosystms	0.30	0.04	15.38%
TSE:MIR	Medmira Inc	0.05	-0.02	-29.33%

Telescope Innovations Corp Corporate Events

Business Operations and Strategy

Telescope Innovations CTO Joins NSF’s US$380 Million Programmable Cloud Labs Kickoff

Positive

Sep 23, 2026

Telescope Innovations Corp. disclosed that its chief technology officer, Prof. Jason Hein, has been invited to participate in the National Science Foundation’s Programmable Cloud Laboratories Test Bed kickoff meeting in Washington, D.C., a high...

Business Operations and StrategyExecutive/Board Changes

Telescope Innovations Adds Veteran Chemist and Tech Founder Dr. Neil Lewis to Board

Positive

Aug 19, 2026

Telescope Innovations Corp., a developer of physical AI systems and autonomous Self-Driving Laboratories for pharmaceutical and high-value chemical companies, has appointed Dr. E. Neil Lewis to its board of directors. The Vancouver-based firm’s...

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Sep 24, 2026

Telescope Innovations Corp AI Stock Analysis